Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Dallas area cornea shortages could benefit from national study

Surgeons and patients from UT Southwestern Medical Center and UT Southwestern Transplant Services Center joined in a landmark study showing that corneas from older donors are as successful for transplants after five years as is tissue from younger donors, allowing possible expansion of the donor pool.

2 Apr 2008

New breakthrough discovery on TB

Medical scientists from the University of Leicester, together with colleagues from St Georges, University of London, funded principally by the Medical Research Council (MRC) and The Wellcome Trust, have published details of a new breakthrough discovery on TB.

1 Apr 2008

Researchers discover how HIV can hide in cells

Researchers have discovered how Human Immunodeficiency Virus (HIV), which causes AIDS, can hide itself in our cells and dodge the attention of our normal defences, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008

New blood pressure drug Micardis (Telmisartan) good at reducing deaths from heart attacks

An international team of researchers have found that a new blood pressure medication is as effective in reducing cardiovascular death, with fewer side effects than the current treatments offered.

1 Apr 2008

Superbugs resistant to everything - Doctors running out of treatments

Doctors are running out of treatments for today's trauma victims and critically ill patients because of infections due to drug resistant microbes even after resorting to using medicines thrown out 20 years ago because of severe side effects, scientists heard at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

1 Apr 2008

Health survey reveals interesting facts about NSW residents

A population survey by the NSW Department of Health has revealed a number of interesting facts.

1 Apr 2008

New blood pressure drug telmisartan has fewer side effects

A major Canadian-led global study has found that a new blood pressure medication is effective in reducing cardiovascular death, with fewer side effects than the current standard of care.

1 Apr 2008

Naglazyme approved in Japan

BioMarin Pharmaceutical Inc. has announced that AnGes MG, Inc. (AnGes), BioMarin's marketing and distribution partner in Japan, has received approval for its Marketing Application for Naglazyme(R) (galsulfase) from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with Mucopolysaccharidosis VI ( MPS VI).

1 Apr 2008

Discovery of role of rare gene mutations in schizophrenia

Using an important new method that can be applied in the study of other psychiatric illnesses, scientists at Cold Spring Harbor Laboratory (CSHL) in collaboration with colleagues at the University of Washington (UW) and the National Institute of Mental Health (NIMH), have identified multiple, individually rare gene mutations in people with schizophrenia that may help explain how that devastating illness is caused.

31 Mar 2008

Simple screening chips could speed up detection of livestock viruses

Some of the worst threats to farm workers and farm animals such as bird flu, foot-and-mouth disease and other emerging viruses could soon be quickly identified by using a simple screening chip developed by scientists from the Institute for Animal Health, scientists will hear today (Monday 31 March 2008) at the Society for General Microbiology's 162nd meeting being held this week at the Edinburgh International Conference Centre.

31 Mar 2008

Americans living longer, enjoying greater health and prosperity, but important disparities remain

Average life expectancy continues to increase, and today's older Americans enjoy better health and financial security than any previous generation.

31 Mar 2008

Ebola virus vaccines for humans

One of the world's deadliest diseases, caused by the Ebola virus, may finally be preventable thanks to US and Canadian researchers, who have successfully tested several Ebola vaccines in primates and are now looking to adapt them for human use.

31 Mar 2008

Another bird flu case in Indonesia - expert says surveillance and strict control measures are the answer

Indonesian health authorities have announced another case of bird flu, bringing the country's total confirmed cases to 130 to date with 105 deaths.

31 Mar 2008

Wistar Institute shares cell lines

Cell lines developed by scientists at The Wistar Institute in Philadelphia have recently been made available to researchers around the globe through the catalog collection at the Coriell Institute for Medical Research of Camden, N.J.

26 Mar 2008

The focus on HIV/AIDS has helped forget the threat of tuberculosis

A leading Australian expert has warned that the international attention devoted to HIV/AIDS has dwarfed the threat of tuberculosis (TB).

25 Mar 2008

PharmAthene signs agreement to acquire biodefense vaccines business from Avecia

PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.

24 Mar 2008

Fewer TB cases recorded but numbers still too high

A small decrease in UK Tuberculosis (TB) cases in 2007, compared with 2006, was reported by the Health Protection Agency today when provisional UK figures were released for World TB Day, but experts warn the number is still too high.

24 Mar 2008

WHO warns Aussies to prepare for deadly flu

The World Health Organisation (WHO) is warning Australians to prepare for a potentially deadly flu season.

23 Mar 2008

Skin patch gives bird flu vaccine a big boost

Researchers testing an experimental skin patch designed to boost an H5N1 vaccine say preliminary results have been promising.

21 Mar 2008

New understanding of Norwalk virus

Using the Canadian Light Source synchrotron, an international team led by University of Calgary researcher Ken Ng has determined the detailed structure of the enzyme the Norwalk virus uses to make copies of its genetic code in order to replicate itself.

20 Mar 2008